Drug information provided by: Merative, Micromedex®
Mavacamten is used to treat symptomatic obstructive hypertrophic cardiomyopathy (HCM). This medicine helps improve your symptoms and ability to be active.
This medicine is available only under a restricted distribution program called Camzyos™ REMS (Risk Evaluation and Mitigation Strategy) Program.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.